Stay updated on Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.

Latest updates to the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, indicating a minor update to the page metadata without altering the study details.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s site footer version was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a general platform release without changing the study record content.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now lists 44 locations for the study; the detailed site list has been trimmed. Revision: v3.5.0 is displayed on the page.SummaryDifference4%

- Check81 days agoChange DetectedVersion update: added Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check102 days agoChange DetectedVersion label updated from v3.4.1 to v3.4.2 in the page footer.SummaryDifference0.0%

Stay in the know with updates to Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.